Skip to main content
Caplight Logo









Exciting Instruments

Exciting Instruments

Private
SheffieldHealthcare & Life Scienceshttps://excitinginstruments.com/

Last Round

Grant

Mar 18, 2025

Total Funding Raised

$5.94M

Company Overview

Exciting Instruments is a healthcare technology company that provides a single-molecule detection platform for life science research in academic and pharmaceutical labs.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

single-molecule spectroscopybenchtop spectrometersmFRETfluorescence correlation spectroscopyFCSfluorescence cross-correlation spectroscopyFCCSdrug discovery toolsmolecular analysislab-in-the-loopautomated microscopybiotech instrumentationscientific softwarebenchtop lab gearAI-driven analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exciting Instruments Comparables

Compare Exciting Instruments with similar companies based on industry and business-model similarity.

Exciting Instruments comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Depixus
73%
Techcomp Instruments
73%
PicoQuant GmbH
73%

Exciting Instruments Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 18, 2025
SeedNov 22, 2024
DebtSep 8, 2022

Key People

Founding team and executive leadership

Tim Craggs

Chief Executive Officer

Executive Team

Exciting Instruments Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 89% MoM to 1.5K.

  • Mar 26, 2026

    Added Health Systems Evidence as a customer.

Exciting Instruments Filings

Explore SEC and related filing metadata, where available.

Exciting Instruments filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Exciting Instruments's valuation, stock price, and market status.

Is Exciting Instruments a public or private company?

Exciting Instruments is a private company.

What is the current stock price of Exciting Instruments?

Exciting Instruments is a private company, so its shares have no public market price. Caplight tracks Exciting Instruments's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Exciting Instruments worth (valuation)?

Valuation information for Exciting Instruments is not publicly available.

Can I buy Exciting Instruments stock?

Exciting Instruments shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Exciting Instruments's last funding round?

Exciting Instruments's most recent funding round was Grant on March 18, 2025.

Who are the main investors in Exciting Instruments?

Key investors in Exciting Instruments include Northern Gritstone.

Will Exciting Instruments IPO soon?

No public IPO plans have been announced for Exciting Instruments.

How can I track Exciting Instruments secondary market activity?

Caplight tracks bids, offers, and trades in Exciting Instruments's shares on secondary markets.

Firmographic Details

HeadquartersSheffield
Employee Range13
Year Founded2021
Last FundingMar 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?